Kidney Stones on Dialysis: Risk Factors and Prevention

Yes, Dialysis Patients Can Form Stones

Dialysis removes solutes but does not eliminate lithogenic risk factors. Stone incidence in dialysis: ~5–15% (higher than general population in some series).

Contributing Factors

  • Altered urine chemistry: Low volume, high pH (metabolic alkalosis from citrate/dialysate), hypocitraturia, hypercalciuria, hyperoxaluria (dietary + endogenous), hyperuricosuria.
  • Anatomic: Cystic kidneys (ADPKD), medullary sponge kidney.
  • Metabolic: Secondary hyperparathyroidism → hypercalcemia; vitamin D analogs.
  • Medications: Topiramate, loop diuretics (if residual function), calcium-based binders.
  • Infection: Urease-producers → struvite stones.

Prevention Strategies

  • Fluid intake: Maximize within prescribed allowance (often 750–1000 mL/day + urine output).
  • Diet: Moderate oxalate, sodium <2g, animal protein 0.8–1.0 g/kg; adequate calcium with meals.
  • Dialysate optimization: Lower calcium bath (2.5→2.0 mEq/L), citrate dialysate (↑ citrate).
  • Medications: Potassium citrate (if hypocitraturic, monitor K⁺), allopurinol (hyperuricosuria), thiazide (if residual GFR >15–20).
  • Treat hyperparathyroidism: Cinacalcet, parathyroidectomy.
  • Surveillance: Periodic KUB/US; stone analysis if passed.

Stone Management

Similar to general population but consider: no contrast (nephrotoxicity), anticoagulation for dialysis access, anesthesia risk. Ureteroscopy/laser preferred over SWL (anatomy, access).

Kidney Disease - Related Articles